TUCSON, Ariz. and LEBANON, N.H., November 29, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a ...
October 17, 2023—The Foundation for Angelman Syndrome Therapeutics (FAST) announced today that the non-profit organization has entered into an exclusive ...
Messenger RNA (mRNA) technology has become popular in the last few years due to its use in COVID-19 vaccines. This ...
Evaluation of potential hepatotoxicity, a detailed knowledge of plasma proteins in physiological and pathological states, and identification of biomarkers and ...
HOUSTON, GOLDEN, Colo. and WATERTOWN, Mass. ― The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a ...
New York, NY—July 10, 2023—As researchers make major advances in medical care, they are also discovering that the efficacy of ...
(Memphis, Tenn.—July 8, 2023) Scientists at St. Jude Children’s Research Hospital created a hepatoblastoma (liver cancer) model that more accurately ...
Artificial Intelligence, Space Food & Polyphenols: 2 Ambitious Projects Credit: Polyphenols Applications Artificial Intelligence, Space Food & Polyphenols: 2 Ambitious ...
NEW YORK, N.Y. — June 2. Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical ...
NEW YORK, NY (May 23) – The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch ...
A world-leading oral health expert from the University of Birmingham, whose pioneering research concentrates on the link between oral health ...
A new research study published in JMIR Diabetes evaluated the real-world effectiveness of the Fitterfly Diabetes CGM digital therapeutic program ...
HOUSTON and SOMERVILLE, Mass. ― The University of Texas MD Anderson Cancer Center and Generate:Biomedicines today announced a strategic collaboration ...
Gaithersburg, MD; April 25, 2023 - Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases ...
WEST LAFAYETTE, Ind. – Purdue Ventures, which manages three funds to support Purdue University-connected startups, has invested $250,000 in TRIO Pharmaceuticals Inc., ...
Gaithersburg, MD—March 28, 2023 – Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and cancer, ...
More than a third of FDA-approved drugs work by targeting a G protein-coupled receptor, or GPCR. The human body has ...
Researchers at the Department of Chemical Engineering, Indian Institute of Technology, India, have investigated the effects of oxidative stress on ...
Both traditional Chinese medicine and modern medicine are crucial for the treatment of diseases. JPA has published several studies exploring ...
Gaithersburg, MD—February 14, 2023 – Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and ...
